JP2006514950A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006514950A5 JP2006514950A5 JP2004560831A JP2004560831A JP2006514950A5 JP 2006514950 A5 JP2006514950 A5 JP 2006514950A5 JP 2004560831 A JP2004560831 A JP 2004560831A JP 2004560831 A JP2004560831 A JP 2004560831A JP 2006514950 A5 JP2006514950 A5 JP 2006514950A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally
- optionally substituted
- aryl
- ring
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43362602P | 2002-12-13 | 2002-12-13 | |
| PCT/US2003/039619 WO2004055010A2 (en) | 2002-12-13 | 2003-12-12 | Cyclopropyl compounds as ccr5 antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006514950A JP2006514950A (ja) | 2006-05-18 |
| JP2006514950A5 true JP2006514950A5 (cg-RX-API-DMAC10.html) | 2007-01-25 |
Family
ID=32595221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004560831A Pending JP2006514950A (ja) | 2002-12-13 | 2003-12-12 | Ｃｃｒ５拮抗薬としてのシクロプロピル化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7569579B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1569934B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2006514950A (cg-RX-API-DMAC10.html) |
| AT (1) | ATE384724T1 (cg-RX-API-DMAC10.html) |
| AU (1) | AU2003296993A1 (cg-RX-API-DMAC10.html) |
| DE (1) | DE60318891T2 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2298627T3 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2004055010A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005007614A1 (en) * | 2003-07-03 | 2005-01-27 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services 6011 | Monoamine oxidase inhibitors |
| ZA200605248B (en) | 2003-12-15 | 2007-10-31 | Japan Tobacco Inc | Cyclopropane compounds and pharmaceutical use thereof |
| BRPI0815591B8 (pt) | 2007-08-22 | 2021-05-25 | Astrazeneca Ab | composto, composição farmacêutica, e, uso de um composto. |
| UA103195C2 (uk) | 2008-08-11 | 2013-09-25 | Глаксосмитклайн Ллк | Похідні пурину для застосування у лікуванні алергій, запальних та інфекційних захворювань |
| BRPI0917458A2 (pt) | 2008-08-11 | 2015-12-01 | Glaxosmithkline Llc | composto, método de tratamento de doenças e condições, composição farmacêutica, método para tratar ou prevenir doença, e, uso de um composto |
| CN102176911B (zh) | 2008-08-11 | 2014-12-10 | 葛兰素史密丝克莱恩有限责任公司 | 新的腺嘌呤衍生物 |
| US8993808B2 (en) | 2009-01-21 | 2015-03-31 | Oryzon Genomics, S.A. | Phenylcyclopropylamine derivatives and their medical use |
| TW201039825A (en) | 2009-02-20 | 2010-11-16 | Astrazeneca Ab | Cyclopropyl amide derivatives 983 |
| WO2011035941A1 (en) | 2009-09-25 | 2011-03-31 | Oryzon Genomics S.A. | Lysine specific demethylase-1 inhibitors and their use |
| US8946296B2 (en) | 2009-10-09 | 2015-02-03 | Oryzon Genomics S.A. | Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their use |
| RS53745B1 (sr) | 2010-02-10 | 2015-06-30 | Glaxosmithkline Llc | 6-amino-2-{[(1s)-1-metilbutil]oksi}-9-[5-(1-piperidinil)pentil]-7,9-dihidro-8h-purin-8-on-maleat |
| US8575340B2 (en) | 2010-02-10 | 2013-11-05 | Glaxosmithkline Llc | Purine derivatives and their pharmaceutical uses |
| AU2011218491C1 (en) | 2010-02-18 | 2015-05-14 | Astrazeneca Ab | Processes for making cyclopropyl amide derivatives and intermediates associated therewith |
| WO2011106106A2 (en) | 2010-02-24 | 2011-09-01 | Oryzon Genomics, S.A. | Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae |
| WO2011106574A2 (en) | 2010-02-24 | 2011-09-01 | Oryzon Genomics, S.A. | Inhibitors for antiviral use |
| RS55348B1 (sr) | 2010-04-19 | 2017-03-31 | Oryzon Gnomics S A | Inhibitori lizin specifične demetilaze-1 i njihova upotreba |
| DK2598482T3 (en) | 2010-07-29 | 2018-06-14 | Oryzon Genomics Sa | ARYLCYCLOPROPYLAMINE-BASED DEMETHYLASE INHIBITORS OF LSD1 AND THEIR MEDICAL USE |
| EP2598480B1 (en) | 2010-07-29 | 2019-04-24 | Oryzon Genomics, S.A. | Cyclopropylamine derivatives useful as lsd1 inhibitors |
| WO2012045883A1 (en) | 2010-10-08 | 2012-04-12 | Oryzon Genomics S.A. | Cyclopropylamine inhibitors of oxidases |
| WO2012072713A2 (en) | 2010-11-30 | 2012-06-07 | Oryzon Genomics, S.A. | Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae |
| EP2712315B1 (en) | 2011-02-08 | 2021-11-24 | Oryzon Genomics, S.A. | Lysine demethylase inhibitors for myeloproliferative disorders |
| US9469597B2 (en) | 2011-10-20 | 2016-10-18 | Oryzon Genomics S.A. | (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors |
| AU2012324803B9 (en) | 2011-10-20 | 2017-08-24 | Oryzon Genomics, S.A. | (hetero)aryl cyclopropylamine compounds as LSD1 inhibitors |
| JO3387B1 (ar) | 2011-12-16 | 2019-03-13 | Glaxosmithkline Llc | مشتقات بيتولين |
| KR20160124157A (ko) | 2014-02-20 | 2016-10-26 | 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 | 인간 인터페론의 유도인자로서의 피롤로[3,2]피리미딘 유도체 |
| ES2917887T3 (es) | 2014-11-13 | 2022-07-12 | Glaxosmithkline Biologicals Sa | Derivados de adenina que son útiles en el tratamiento de enfermedades alérgicas u otras afecciones inflamatorias |
| JP6411676B2 (ja) | 2015-12-03 | 2018-10-24 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ | Ｓｔｉｎｇの調節因子としての環状プリンジヌクレオチド |
| SG10201900628RA (en) | 2016-04-07 | 2019-02-27 | Glaxosmithkline Ip Dev Ltd | Heterocyclic amides useful as protein modulators |
| WO2017175156A1 (en) | 2016-04-07 | 2017-10-12 | Glaxosmithkline Intellectual Property Development Limited | Heterocyclic amides useful as protein modulators |
| US11377440B2 (en) | 2017-10-05 | 2022-07-05 | Glaxosmithkline Intellectual Property Development Limited | Modulators of stimulator of interferon genes (STING) |
| AU2018344902B2 (en) | 2017-10-05 | 2021-06-03 | Glaxosmithkline Intellectual Property Development Limited | Modulators of stimulator of interferon genes (STING) useful in treating HIV |
| GB201807924D0 (en) | 2018-05-16 | 2018-06-27 | Ctxt Pty Ltd | Compounds |
| JP2022533390A (ja) | 2019-05-16 | 2022-07-22 | スティングセラ インコーポレイテッド | オキソアクリジニル酢酸誘導体および使用方法 |
| US20220251079A1 (en) | 2019-05-16 | 2022-08-11 | Stingthera, Inc. | Benzo[b][1,8]naphthyridine acetic acid derivatives and methods of use |
| GB201910305D0 (en) | 2019-07-18 | 2019-09-04 | Ctxt Pty Ltd | Compounds |
| GB201910304D0 (en) | 2019-07-18 | 2019-09-04 | Ctxt Pty Ltd | Compounds |
| WO2021119753A1 (en) | 2019-12-18 | 2021-06-24 | Ctxt Pty Limited | Compounds |
| US11116737B1 (en) | 2020-04-10 | 2021-09-14 | University Of Georgia Research Foundation, Inc. | Methods of using probenecid for treatment of coronavirus infections |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1044282A1 (zh) * | 1998-12-18 | 2002-10-18 | Bristol-Myers Squibb Pharma Company | 作为趋化因子受体活性调节剂的n-脲基烷基-哌啶化合物 |
| US6331541B1 (en) * | 1998-12-18 | 2001-12-18 | Soo S. Ko | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| PE20001420A1 (es) | 1998-12-23 | 2000-12-18 | Pfizer | Moduladores de ccr5 |
| US7217714B1 (en) | 1998-12-23 | 2007-05-15 | Agouron Pharmaceuticals, Inc. | CCR5 modulators |
| WO2002066468A2 (en) * | 2001-02-16 | 2002-08-29 | Aventis Pharmaceuticals Inc. | Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands |
-
2003
- 2003-12-12 ES ES03813416T patent/ES2298627T3/es not_active Expired - Lifetime
- 2003-12-12 AU AU2003296993A patent/AU2003296993A1/en not_active Abandoned
- 2003-12-12 EP EP03813416A patent/EP1569934B1/en not_active Expired - Lifetime
- 2003-12-12 JP JP2004560831A patent/JP2006514950A/ja active Pending
- 2003-12-12 WO PCT/US2003/039619 patent/WO2004055010A2/en not_active Ceased
- 2003-12-12 DE DE60318891T patent/DE60318891T2/de not_active Expired - Lifetime
- 2003-12-12 AT AT03813416T patent/ATE384724T1/de not_active IP Right Cessation
- 2003-12-12 US US10/538,196 patent/US7569579B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006511555A5 (cg-RX-API-DMAC10.html) | ||
| JP2006511552A5 (cg-RX-API-DMAC10.html) | ||
| JP2006512339A5 (cg-RX-API-DMAC10.html) | ||
| JP5450434B2 (ja) | 関節炎の治療方法 | |
| AU2014277506B2 (en) | Bisulfate of Janus kinase (JAK) inhibitor and preparation method therefor | |
| JP2002543185A5 (cg-RX-API-DMAC10.html) | ||
| RU2006144709A (ru) | Земещенные 2-хинолилоксазолы, пригодные в качестве ингибиторы фдэ4 | |
| WO2018057973A4 (en) | Compounds and methods for ido and tdo modulation, and indications therefor | |
| JP2011516428A5 (cg-RX-API-DMAC10.html) | ||
| RU2013154117A (ru) | Производные 1-фенил-2-пиридинилалкильных спиртов в качестве ингибиторов фосфодиэстеразы | |
| RU2010150799A (ru) | НОВАЯ КРИСТАЛЛИЧЕСКАЯ И АМОРФНАЯ ФОРМА ТРИАЗОЛО(4,5-d)ПИРИМИДИНА | |
| CN106573006A (zh) | 作为药物的rip1激酶抑制剂杂环酰胺 | |
| RU2006105716A (ru) | Производные пиридазина и их применение в качестве терапевтических средств | |
| RU2015120216A (ru) | Ингибиторы тирозинкиназы брутона | |
| JP2008526761A5 (cg-RX-API-DMAC10.html) | ||
| RU2015105262A (ru) | Азотсодержащие гетероциклические производные и их применение в фармацевтических препаратах | |
| JP2011506412A5 (cg-RX-API-DMAC10.html) | ||
| RU2006130684A (ru) | Бензамидные производные и их применение в качестве активирующих глюкокиназу агентов | |
| JP2017510643A5 (cg-RX-API-DMAC10.html) | ||
| RU2016150326A (ru) | Производные изоиндолина для применения в лечении вирусной инфекции | |
| JP2002535401A5 (cg-RX-API-DMAC10.html) | ||
| RU2007120454A (ru) | Производные хинуклидина и их применение в качестве антагонистов мускариновых рецепторов м3 | |
| RU2011117927A (ru) | Карбаматное соединение или его соль | |
| RU99112569A (ru) | Бициклические арильные карбоксамиды и их терапевтическое применение | |
| Majewski et al. | Design, syntheses, and anti-tuberculosis activities of conjugates of piperazino-1, 3-benzothiazin-4-ones (pBTZs) with 2, 7-dimethylimidazo [1, 2-a] pyridine-3-carboxylic acids and 7-phenylacetyl cephalosporins |